-+ 0.00%
-+ 0.00%
-+ 0.00%

Processa Pharma Q3 2024 GAAP EPS $(1.03) Misses $(1.00) Estimate

Benzinga·10/30/2024 21:00:16
Listen to the news
Processa Pharma (NASDAQ:PCSA) reported quarterly losses of $(1.03) per share which missed the analyst consensus estimate of $(1.00) by 3 percent.